Success Stories: Thanks to Premium Processing, an Indian Research Support Specialist in the Field of Cell Biology Obtains EB1A Approval in Just 6 Days

 

Client’s Testimonial:

“It was great working with you. Thank you!”


On January 24th, 2024, we received another EB-1A (Alien of Extraordinary Ability) approval for a Senior Research Support Specialist in the field of Cell Biology (Approval Notice).


General Field: Cell Biology

Position at the Time of Case Filing: Senior Research Support Specialist

Country of Origin: India

State of Residence at the Time of Filing: New York

Approval Notice Date: January 24th, 2024

Processing Time: 6 days (Premium Processing Requested)


Case Summary:

After USCIS established stringent rules for the requirements to qualify as an Alien of Extraordinary Ability under the EB1-A program, the petitioner must demonstrate, beyond a reasonable doubt, the merit of their application by demonstrating how their work benefits the United States. If a petitioner is not familiar with the system, this process can be tedious and slow. North America Immigration Law Group can help in this situation. We help our clients from all over the world grasp trends and stay ahead of them, guaranteeing their success.

Therefore, when our client from India came to us asking for help with his EB1-A case, we discovered that he is a senior research support specialist working in the field of cell biology. Having earned a Ph.D. in biophysics, he wanted us to build a strong case for him. So, he provided us with extensive details of his research, along with many independent citations of his work, updated CV and other relevant documents. Our team then summarised information about his academic and professional background in a format USCIS understands better. We included the following things in his petition packet:

  • We highlighted that our client seeks to continue his work in the field of cell biology. He currently focuses on protein functions and has already greatly advanced the national interest by providing foundational information for drug development and biomedical engineering.
  • We deduced that his biological microscopy research addresses some of our nation’s and the world’s most pressing issues, including cancer treatment, cardiovascular diseases, and drug discovery.
  • The field further has recognized his expertise by inviting him to review and evaluate the work of his peers at least 35 times.
  • Moreover, his work has resulted in 28 peer-reviewed original research articles, published in some of the most discerning, high-impact journals and conference proceedings in his field.
  • Also, due to its great applicability in the field, his research has been cited 861 times in other peer-reviewed journal articles according to Google Scholar. These publications have been cited by researchers in at least 47 countries, thereby illustrating that these publications are widely recognized and relied upon in his field of expertise.
  • Moreover, his study has been supported by funding from the National Institutes of Health (NIH). This support to his research serves as evidence that he is progressing with cancer diagnosis and treatment.
  • To further support his claim, we included excerpts from independent letters of support in his application. One of them stated the following.
“Overall, [client] has made considerable strides in elucidating the essential functions and unique structures of proteins relevant to disease states, thereby supporting the development of new drugs and novel therapeutics for related pathologies such as cancer. Moreover, this endeavor improves the efficacy and overall performance of cancer therapeutics, directly contributing to reduced mortality rates of cancer and improved patient health outcomes. As such, he represents an irreplaceable resource for the United States and to the cell biology field.”

In addition to his exceptional qualifications as an alien of extraordinary ability, all of these factors—along with his remarkable background, a stellar record of accomplishments in the past, recognition of his expertise by journals seeking his services to review manuscripts, and unique knowledge pertinent to his current and future work—indicate that his entry will potentially benefit the United States significantly. With the support of these details and the superb case preparation technique our specialists used, he was able to get his EB1-A (Alien of Extraordinary Ability) application approved in just six days. We are appreciative of his ongoing faith in us. We hope for the best for him in life.